Three PCR methods based on the GB virus-C/ hepatitis G virus (GBV-C/HGV) 5ΠUTR and NS3 genomic region were used for the detection of GBV-C/HGV RNA in serum of 62 patients with chronic hepatitis C virus (HCV) infection. Ten of 62 (16%) patients were found to have GBV-C/ HGV RNA, which was confirmed b
Quantification of Hepatitis C Virus RNA by Competitive Reverse Transcription and Polymerase Chain Reaction Using a Modified Hepatitis C Virus RNA Transcript
β Scribed by B. Ruster; S. Zeuzem; W.K. Roth
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 342 KB
- Volume
- 224
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Eq/mL, P Γ΅ .01). There was no difference in the pre-Hepatitis C virus (HCV) replicates at a low rate, treatment proportion of HCV RNA -positive hepatoand this makes its detection and intrahepatic localcytes among patients with different biochemical reization difficult. To evaluate the clinical impli
The combination of reverse transcription and polymerase chain reaction is a very powerful tool for the detection of hepatitis C virus RNA in sera of patients with hepatitis C virus infection. However, when studying the presence of this virus in tissue using polymerase chain reaction, it may be diffi
## Abstract The mean prevalence of antiβhepatitis C virus (HCV) in Italy is 0.87%. It reaches 2% in Campania, Southern Italy. Approximately 50% of community acquired nonβA, nonβB (NANB) hepatitis cannot be associated with known parenteral exposure. A recent Italian study has shown that the only dem
GBV-C might be a causative agent of fulminant hepatitis of unknown etiology. Fulminant hepatitis is an indication for liver transplantation. However, in Japan, because of the legal difficulties associated with cadaveric donation, patients with fulminant hepatitis are still treated by plasmapheresis
A study was carried out to assess the correlation between the serum concentration of hepatitis C virus RNA (HCV-RNA) in patients with chronic hepatitis, as measured by competitive reverse transcription polymerase chain reaction (cRT-PCR) and branched DNA probe assay (bDNA), and response to interfero